Categories: The Charlton Centre

Charlton Health at the Canadian Rheumatology Association

Our pharmacists Carolyn Whiskin and Janice Maretzki recently attended the Canadian Rheumatology Association meeting in Montreal. Charlton Health was very proud to have been selected to present our practice research project at this meeting. A large poster outlining the project is on display in our Hamilton office.

The objective of the project was to improve patient confidence and understanding of their disease and treatment through a pharmacist led consultation prior to initiation and choice of treatment of an advanced therapy such as a biologic. Patients were toured through our infusion clinic, shown all the self injection devices and were educated on the newest oral therapies. In addition, vaccines were updated, insurance status evaluated and smoking cessation counselling offered. The patients were then asked which treatments they would feel most comfortable taking. A report was then sent to their referring physician.

The results of this project were that patients understanding of their disease increased by 33% and understanding of their treatment increased by 187%. On a scale of 1-4, confidence and understanding of their treatment increased from an average score of 1.66 to 3.88 after the visit with the pharmacist.

A second phase of this project is now underway.

Highlights of this conference will shared in future blogs… stay tuned for more!


Carolyn Whiskin is the Pharmacy Manager for Charlton Health.  Carolyn specializes in the treatment of autoimmune diseases, pharmaceutical compounding, women’s health, pain and smoking cessation. Carolyn has won provincial and national awards for her commitment to patient care and public service.

admin

Recent Posts

Winrevair: A New Treatment Option for Pulmonary Arterial Hypertension (PAH)

Pulmonary arterial hypertension occurs when there is increased pressure in the small blood vessels that…

1 week ago

New Biologic Treatment for PMR (Polymyalgia Rheumatica)

Polymyalgia rheumatica (PMR) is an inflammatory condition that causes widespread joint and muscle pain along…

3 weeks ago

Expanded Protection: RSV Vaccine Now Approved for More Adults

Respiratory Syncytial Virus (RSV) is a common virus that can cause serious lung infections, particularly in…

1 month ago

Rinvoq: A New Oral Option for Giant Cell Arteritis

Health Canada has recently approved Rinvoq (upadacitinib) for adults living with Giant Cell Arteritis (GCA). Rinvoq…

2 months ago

World Arthritis and Mental Health Day: October 2025

Every year on October 12, World Arthritis Day raises awareness about the millions of people…

2 months ago

Tremfya: New Dosing Options for Crohn’s Disease and Ulcerative Colitis

Tremfya (guselkumab) has been available for several years to treat plaque psoriasis and psoriatic arthritis.…

3 months ago